Differential role for phospholipase D1 and phospholipase D2 in 12-O-tetradecanoyl-13-phorbol acetate-stimulated MAPK activation, Cox-2 and IL-8 expression

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1636, Issue 1, 2004, Pages 29-39

  Grab, Leslie T ^a   Kearns, Mary W ^a   Morris, Andrew J ^b   Daniel, Larry W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Extracellular regulated protein kinase; Mitogen activated protein kinase; Phospholipase D

Indexed keywords

CYCLOOXYGENASE 2; GROWTH FACTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; SYNAPTOPHYSIN;

ARTICLE; CELL FREE SYSTEM; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

EID: 1242314722     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2003.12.002     Document Type: Article

References (48)

1. Colley W.C., Sung T.C., Roll R., Jenco J., Hammond S.M., Altshuller Y., Bar-Sagi D., Morris A.J., Frohman M.A. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7:1997;191-201.
2. Hammond S.M., Altshuller Y.M., Sung T.C., Rudge S.A., Rose K., Engebrecht J., Morris A.J., Frohman M.A. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J. Biol. Chem. 270:1995;29640-29643.
3. Hammond S.M., Jenco J.M., Nakashima S., Cadwallader K., Gu Q.-M., Cook S., Nozawa Y., Prestwich G.D., Frohman M.A., Morris A.J. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J. Biol. Chem. 272:1997;3860-3868.
4. Zhong M., Joseph T., Jackson D., Beychenok S., Foster D.A. Elevated phospholipase D activity induces apoptosis in normal rat fibroblasts. Biochem. Biophys. Res. Commun. 298:2002;474-477.
5. Joseph T., Wooden R., Bryant A., Zhong M., Lu Z., Foster D.A. Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. Biochem. Biophys. Res. Commun. 289:2001;1019-1024.
6. Park D.W., Bae Y.S., Nam J.O., Kim J.H., Lee Y.G., Park Y.K., Ryu S.H., Baek S.H. Regulation of cyclooxygenase-2 expression by phospholipase D in human amnion-derived WISH cells. Mol. Pharmacol. 61:2002;614-619.
7. Wang L., Cummings R., Usatyuk P., Morris A., Irani K., Natarajan V. Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells. Biochem. J. 367:2002;751-760.
8. Cummings R.J., Parinandi N.L., Zaiman A., Wang L., Usatyuk P.V., Garcia J.G., Natarajan V. Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells. J. Biol. Chem. 277:2002;30227-30235.
9. Sciorra V.A., Daniel L.W. Phospholipase D-derived products in the regulation of 12-O-tetradecanoylphorbol-13-acetate-stimulated prostaglandin synthesis in Madin-Darby canine kidney cells. J. Biol. Chem. 271:1996;14226-14232.
10. Ghosh S., Bell R.M. Regulation of Raf-1 kinase by interaction with the lipid second messenger, phosphatidic acid. Biochem. Soc. Trans. 25:1997;561-565.
11. Rizzo M.A., Shome K., Vasudevan C., Stolz D.B., Sung T.C., Frohman M.A., Watkins S.C., Romero G. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 274:1999;1131-1139.
12. Bechoua S., Daniel L.W. Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine. J. Biol. Chem. 276:2001;31752-31759.
13. Lee C.S., Bae Y.S., Lee S.D., Suh P.G., Ryu S.H. ATP-induced mitogenesis is modulated by phospholipase D2 through extracellular signal regulated protein kinase dephosphorylation in rat pheochromocytoma PC12 cells. Neurosci. Lett. 313:2001;117-120.
14. Lee M.J., Oh J.Y., Park H.T., Uhlinger D.J., Kwak J.Y. Enhancement of phospholipase D activity by overexpression of amyloid precursor protein in P19 mouse embryonic carcinoma cells. Neurosci. Lett. 315:2001;159-163.
15. Koki A.T., Khan N.K., Woerner B.M., Seibert K., Harmon J.L., Dannenberg A.J., Soslow R.A., Masferrer J.L. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukot. Essent. Fat. Acids. 66:2002;13-18.
16. Koki A.T., Masferrer J.L. Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control. 9:2002;28-35.
17. Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J. Periodontol. 64:1993;456-460.
18. Mukaida N., Harada A., Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev. 9:1998;9-23.
19. Sung T.C., Roper R.L., Zhang Y., Rudge S.A., Temel R., Hammond S.M., Morris A.J., Moss B., Engebrecht J., Frohman M.A. Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J. 16:1997;4519-4530.
20. Wakelam M.J., Cook S.J., Currie S., Palmer S., Plevin R. Regulation of the hydrolysis of phosphatidylcholine in Swiss 3T3 cells. Biochem. Soc. Trans. 19:1991;321-324.
21. Brown H.A., Gutowski S., Moomaw C.R., Slaughter C., Sternweis P.C. ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell. 75:1993;1137-1144.
22. Bligh D.G., Dyer W.J. Can. J. Biochem. Physiol. 123:1959;64-70.
23. Meier K.E., Gibbs T.C., Knoepp S.M., Ella K.M. Expression of phospholipase D isoforms in mammalian cells. Biochim. Biophys. Acta. 1439:1999;199-213.
24. Rolli M., Kotlyarov A., Sakamoto K.M., Gaestel M., Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. J. Biol. Chem. 274:1999;19559-19564.
25. Reiser C.O., Lanz T., Hofmann F., Hofer G., Rupprecht H.D., Goppelt-Struebe M. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins. Biochem. J. 330:1998;1107-1114.
26. Liu C., Rangnekar V.M., Adamson E., Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 5:1998;3-28.
27. Luquain C., Singh A., Wang L., Natarajan V., Morris A.J. Role of phospholipase D in agonist stimulated lysophosphatidic acid synthesis by ovarian cancer cells. J. Lipid Res. 2003;. (M300188-JLR200).
28. Eder A.M., Sasagawa T., Mao M., Aoki J., Mills G.B. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin. Cancer Res. 6:2000;2482-2491.
29. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72:2002;847-855.
30. Humeau Y., Vitale N., Chasserot-Golaz S., Dupont J.L., Du G., Frohman M.A., Bader M.F., Poulain B. A role for phospholipase D1 in neurotransmitter release. Proc. Natl. Acad. Sci. U. S. A. 98:2001;15300-15305.
31. Ahn M., Min D.S., Kang J., Jung K., Shin T. Increased expression of phospholipase D1 in the spinal cords of rats with experimental autoimmune encephalomyelitis. Neurosci. Lett. 316:2001;95-98.
32. Min D.S., Choi J.S., Chun M.H., Chung J.W., Lee M.Y. Transient expression of phospholipase D1 in developing rat hippocampus. Neurosci. Lett. 310:2001;125-128.
33. Min D.S., Lee K.H., Chang J.S., Ahn B.H., Rhie D.J., Yoon S.H., Hahn S.J., Kim M.S., Jo Y.H. Altered expression of phospholipase D1 in spontaneously hypertensive rats. Mol. Cells. 11:2001;386-391.
34. Hube B., Hess D., Baker C.A., Schaller M., Schafer W., Dolan J.W. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology. 147:2001;879-889.
35. Noh D.Y., Ahn S.J., Lee R.A., Park I.A., Kim J.H., Suh P.G., Ryu S.H., Lee K.H., Han J.S. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 161:2000;207-214.
36. Kam Y., Exton J.H. Phospholipase D activity is required for actin stress fiber formation in fibroblasts. Mol. Cell. Biol. 21:2001;4055-4066.
37. Hong J.H., Oh S.O., Lee M., Kim Y.R., Kim D.U., Hur G.M., Lee J.H., Lim K., Hwang B.D., Park S.K. Enhancement of lysophosphatidic acid-induced ERK phosphorylation by phospholipase D1 via the formation of phosphatidic acid. Biochem. Biophys. Res. Commun. 281:2001;1337-1342.
38. Bae Y.S., Ryu S.H. ATP-induced focal adhesion kinase activity is negatively modulated by phospholipase D2 in PC12 cells. Exp. Mol. Med. 33:2001;150-155.
39. Banno Y., Wang S., Ito Y., Izumi T., Nakashima S., Shimizu T., Nozawa Y. Involvement of ERK and p38 MAP kinase in oxidative stress-induced phospholipase D activation in PC12 cells. NeuroReport. 12:2001;2271-2275.
40. Banno Y., Takuwa Y., Akao Y., Okamoto H., Osawa Y., Naganawa T., Nakashima S., Suh P.G., Nozawa Y. Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3. J. Biol. Chem. 276:2001;35622-35628.
41. Banno Y., Takuwa Y., Yamada M., Takuwa N., Ohguchi K., Hara A., Nozawa Y. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells. Biochem. J. 369:2003;363-368.
42. Ricciardiello L., Roda E., Bazzoli F. Chemoprevention in colorectal neoplasias: what is practical and feasible? Dig. Dis. 20:2002;70-72.
43. Dang C.T., Shapiro C.L., Hudis C.A. Potential role of selective COX-2 inhibitors in cancer management. Oncology (Huntingt.). 16:2002;30-36.
44. Moran E.M. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J. Environ. Pathol. Toxicol. Oncol. 21:2002;193-201.
45. Reddy B.S., Rao C.V. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors. J. Environ. Pathol. Toxicol. Oncol. 21:2002;155-164.
46. Norrby K. Mast cells and angiogenesis. APMIS. 110:2002;355-371.
47. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res. 55:2000;15-35.
48. Xu L., Frankel P., Jackson D., Rotunda T., Boshans R.L., D'Souza-Schorey C., Foster D.A. Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6. Mol. Cell. Biol. 23:2003;645-654.